A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
First in Human Study of YB1-X7 Injection
- Status
- NOT_YET_RECRUITING
- Phase
- NA
First-In-Human Study in Participants With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
HW071021 Monotherapy in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PHST001 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Status
- RECRUITING
- Phase
- PHASE1
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
- Status
- RECRUITING
- Phase
- PHASE1
SKB445 for Injection in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2